Quality of Life in Patients With Bladder Cancer

N/AActive Not RecruitingNCT00745355

Memorial Sloan Kettering Cancer Center550 enrolled

Overview

The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.

Study Type

OBSERVATIONAL

Enrollment

550

Conditions

Bladder Cancer

Interventions

Quality Of Life questionnairesBEHAVIORAL

All patients who agree to participate will be interviewed using a baseline idiographic quality of life assessment prior to surgery and at approximately 6, 12, 18 and 24 months postoperatively. All patients will also be asked to respond to a questionnaire including all standard measures (closed-ended, multiple choice items) before surgery and at approximately 3, 6, 12, 18 and 24 months post-surgery.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients (male and female) who are diagnosed with bladder cancer * Patients must be scheduled for radical cystectomy and urinary diversion are and/or being evaluated for neo-adjuvant chemotherapy prior to a planned cystectomy. * Participants must be able to speak English. * Participants must be able to provide informed consent. * Participants must be 18 years of age or older to enroll. * Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy. * Participant may have had intravesicle chemotherapy or immunotherapy (BCG, Interferon). Exclusion Criteria: * Subjects may be excluded from the study based on the following criteria: * Follow-up care not obtained at MSKCC. * Metastatic disease at diagnosis.

Locations (1)

Memorial Sloan-Kettering Cancer Center

New York, New York, United States

Outcomes

Primary Outcomes

Prospectively characterize the impact of radical cystectomy and different urinary diversions on quality of life of bladder cancer patients.

Time frame: conclusion of study

Secondary Outcomes

Compare various standard and idiographic measures of QOL, to determine their relative contributions in accounting for variance in key outcome criteria and prediction of patient QOL at subsequent assessment points.

Time frame: conclusion of study

Examine how patients react to more in-depth probing of the interview associated with idiographic assessment.

Time frame: conclusion of study

Develop a predictive model of QOL after radical cystectomy & urinary diversion using the data from idiographic and standard QOL measures. This model can ultimately be used in office based practice to guide treatment planning with each patient.

Time frame: conclusion of study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.